Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4123)	6/14/2001 11:29:55 AM
From: Biomaven	Read Replies (2) of 52153

One biotech that seems to have dropped off the radar screens is NRGN. Volume has dried up, spreads are huge and the price performance this year has been weak. I guess the TA guys would run for the hills, but I've been buying. Solid fundamentals and it's quite cheap compared with other quality biotechs. One warning is that trading NRGN currently feels like trading a BB stock - if you don't want to pay the outrageous spread you have to be very patient. I sat for nearly the whole day yesterday inside the spread before I finally filled my purchase. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next